Statistics for Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy.
Total visits
| views | |
|---|---|
| Genetic risk analysis of a patient with fulminant autoimmune type 1 diabetes mellitus secondary to combination ipilimumab and nivolumab immunotherapy. | 146 |
Total visits per month
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 0 |
| January 2025 | 0 |
File Visits
| views | |
|---|---|
| Brent Hanks_2016 JITC Case Report.pdf | 156 |
Top country views
| views | |
|---|---|
| Germany | 34 |
| United Kingdom | 23 |
| United States | 13 |
| South Korea | 3 |
| Singapore | 2 |
| China | 1 |
| France | 1 |
| Moldova | 1 |
Top city views
| views | |
|---|---|
| Kiez | 20 |
| Alexandria | 8 |
| Gaithersburg | 5 |
| Seoul | 3 |
| Changi | 2 |
| Woodbridge | 2 |
| Ann Arbor | 1 |
| Chisinau | 1 |
| Durham | 1 |
| Houston | 1 |
| Old Bridge | 1 |
| Yinchuan | 1 |
| Yulee | 1 |